Women’s Choice Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Women's Choice Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10563
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Women’s Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that offers prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diabetes, hormonal changes, compromised immune system, antibiotics, steroids and lifestyle; iron and succinic acid tablets; Urogesic Blue, a tablet used for the treatment of hypermotility, irritative voiding, urinary tract infections and discomfort from urinary diagnostic procedures; and others. The company markets its products through tele-sales and sales representatives across the US. WCP is headquartered in Berwyn, Pennsylvania, the US.

Women’s Choice Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Women’s Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 10
PharmaDerm and MediGene Enter into Agreement with Women’s Choice Pharma 11
Licensing Agreements 12
Women’s Choice Pharma Enters into Licensing Agreement with Pharmics 12
Acquisition 13
Women’s Choice Pharma Acquires Edwards Pharma 13
Italfarmaco Acquires 30% Stake in Women’s Choice Pharma 14
Women’s Choice Pharmaceuticals LLC – Key Competitors 15
Women’s Choice Pharmaceuticals LLC – Key Employees 16
Women’s Choice Pharmaceuticals LLC – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Women's Choice Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Fougera Pharma Enters into Co-Promotion Agreement with Women’s Choice Pharma for Veregen 10
PharmaDerm and MediGene Enter into Agreement with Women’s Choice Pharma 11
Women's Choice Pharma Enters into Licensing Agreement with Pharmics 12
Women's Choice Pharma Acquires Edwards Pharma 13
Italfarmaco Acquires 30% Stake in Women’s Choice Pharma 14
Women's Choice Pharmaceuticals LLC, Key Competitors 15
Women's Choice Pharmaceuticals LLC, Key Employees 16

List of Figures
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Women's Choice Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Women’s Choice Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AVI Ltd:企業の戦略・SWOT・財務分析
    AVI Ltd - Strategy, SWOT and Corporate Finance Report Summary AVI Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Dart Group PLC:企業の戦略・SWOT・財務情報
    Dart Group PLC - Strategy, SWOT and Corporate Finance Report Summary Dart Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Intrexon Corp (XON):企業の財務・戦略的SWOT分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a synthetic biology service provider. The company operates through its divisions and units such as cell engineering, data sciences and computational biology, information technology (IT), actobiotics, molecular engineering, agricultural bio …
  • Emera Inc.:企業の戦略・SWOT・財務情報
    Emera Inc. - Strategy, SWOT and Corporate Finance Report Summary Emera Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Fletcher Building Ltd:企業の戦略・SWOT・財務情報
    Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report Summary Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole …
  • Acacia Research Corp:企業のM&A・事業提携・投資動向
    Acacia Research Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acacia Research Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • FedEx Corporation (FDX):企業の財務・戦略的SWOT分析
    FedEx Corporation (FDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Barry Callebaut AG:企業の戦略・SWOT・財務情報
    Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report Summary Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vectren Corp (VVC):企業の財務・戦略的SWOT分析
    Vectren Corp (VVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Inframark LLC:企業の戦略的SWOT分析
    Inframark LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Groupe PSA:企業の戦略・SWOT・財務情報
    Groupe PSA - Strategy, SWOT and Corporate Finance Report Summary Groupe PSA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AEP Texas Inc:企業の戦略的SWOT分析
    AEP Texas Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Pioneer Natural Resources Co (PXD):石油・ガス:M&Aディール及び事業提携情報
    Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activities i …
  • Dairyland Power Cooperative:発電所・企業SWOT分析
    Dairyland Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • hopTo Inc. (HPTO):企業の財務・戦略的SWOT分析
    hopTo Inc. (HPTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GOME Electrical Appliances Holding Limited:企業の戦略・SWOT・財務情報
    GOME Electrical Appliances Holding Limited - Strategy, SWOT and Corporate Finance Report Summary GOME Electrical Appliances Holding Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Royal Dutch Shell Plc (RDSA):石油・ガス:M&Aディール及び事業提携情報
    Summary Royal Dutch Shell Plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • CanAlaska Uranium Ltd (CVV):企業の財務・戦略的SWOT分析
    Summary CanAlaska Uranium Ltd (CanAlaska) is a mining and mineral exploration and development company that acquires, explores and develops uranium properties in Athabasca basin of Canada. The company offers projects such as Diamond projects, Cree East project, Fond du Lac project, West McArthur proj …
  • Medtronic Plc (MDT):医療機器:M&Aディール及び事業提携情報
    Summary Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆